1 - 25 of 6
Number of results to display per page
CreatorTitleDescriptionSubjectDate
1 Kendell, IsaacImmunomodulation improves cancer cell clearance by T cells during multi-antigent T cell hybridizer therapyTreatment of hematopoietic malignancies is challenging due to systemic side effects of current treatments and the possibility of relapse. Multi-antigen T cell hybridizer (MATCH) therapy is a novel treatment system composed of antibody fragments conjugated with morpholino oligonucleotides, which hybr...2024
2 Vetter, MikeyInhibition of FAK and AKT as potential therapies for melanoma brain metastasisBrain metastasis is the leading cause of death in patients with advanced melanoma. Melanoma diagnoses nearly reached 100,000 in 2019, and melanoma patients make up 10% of all patients with brain metastasis [1]. The roles of the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinos...vehicle control; previously2021
3 Hyer, Christina CottrellEffect of M1 Matrix Protein on Hemagglutinin Expression and Influenza Virus-Like Particle Production in Trichoplusia NIVirus-like particles (VLPs) are a new and effective flu vaccine approach. VLPs are non-infectious and can produce robust immune responses. Flu VLPs are typically created by co-expressing the flu hemagglutinin (HA) surface antigen and the matrix protein M1-which assists in viral and VLP budding-in cu...2017
4 Slominski, Emma N.Comparison of transcranial MR-guided focused ultrasound phase correction simulations to clinically measured MRTIEssential tremor and Parkinson's disease are neurological disorders causing involuntary shaking that affects an estimated 8 million people in the United States. Transcranial Magnetic Resonance-guided Focused Ultrasound (tcMRgFUS) is a noninvasive alternative method of treating tremors to the invasiv...2021
5 Armstrong, Blair P.Lower critical solution temperature behavior of elastin-coiled-coil polymer, a potential platform for treatment of non-hodgkin's lymphomaNon-Hodgkin's lymphoma takes the lives of 20,000 Americans each year. When traditional therapies fail, clinicians have turned to a drug, rituximab, for treatment. However, rituximab is now curative for less than 50% of patients and new treatments are needed. Drug-free macromolecular therapeutics (DF...2021
6 Frederiksen, HunterPharmacokinetics of Locally Delivered Vancomycin as a Powder & in a HydrogelOrthopedic surgeons currently administer powder vancomycin directly over surgical sites in order to mitigate infections. Local antibiotic administration has been effective at reducing infections; however, there have been few preliminary studies investigating the pharmacokinetics of locally delivered...2018
1 - 25 of 6